BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34099720)

  • 1. Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics.
    Wilhelm M; Zolg DP; Graber M; Gessulat S; Schmidt T; Schnatbaum K; Schwencke-Westphal C; Seifert P; de Andrade Krätzig N; Zerweck J; Knaute T; Bräunlein E; Samaras P; Lautenbacher L; Klaeger S; Wenschuh H; Rad R; Delanghe B; Huhmer A; Carr SA; Clauser KR; Krackhardt AM; Reimer U; Kuster B
    Nat Commun; 2021 Jun; 12(1):3346. PubMed ID: 34099720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Learning-Assisted Analysis of Immunopeptidomics Data.
    Gabriel W; Picciani M; The M; Wilhelm M
    Methods Mol Biol; 2024; 2758():457-483. PubMed ID: 38549030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment ion intensity prediction improves the identification rate of non-tryptic peptides in timsTOF.
    Adams C; Gabriel W; Laukens K; Picciani M; Wilhelm M; Bittremieux W; Boonen K
    Nat Commun; 2024 May; 15(1):3956. PubMed ID: 38730277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry.
    Lorente E; Marcilla M; de la Sota PG; Quijada-Freire A; Mir C; López D
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.
    Partridge T; Nicastri A; Kliszczak AE; Yindom LM; Kessler BM; Ternette N; Borrow P
    Front Immunol; 2018; 9():912. PubMed ID: 29780384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.
    Freudenmann LK; Marcu A; Stevanović S
    Immunology; 2018 Jul; 154(3):331-345. PubMed ID: 29658117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
    Shahbazy M; Ramarathinam SH; Illing PT; Jappe EC; Faridi P; Croft NP; Purcell AW
    Mol Cell Proteomics; 2023 Apr; 22(4):100515. PubMed ID: 36796644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.
    Chong C; Marino F; Pak H; Racle J; Daniel RT; Müller M; Gfeller D; Coukos G; Bassani-Sternberg M
    Mol Cell Proteomics; 2018 Mar; 17(3):533-548. PubMed ID: 29242379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHCquant: Automated and Reproducible Data Analysis for Immunopeptidomics.
    Bichmann L; Nelde A; Ghosh M; Heumos L; Mohr C; Peltzer A; Kuchenbecker L; Sachsenberg T; Walz JS; Stevanović S; Rammensee HG; Kohlbacher O
    J Proteome Res; 2019 Nov; 18(11):3876-3884. PubMed ID: 31589052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.
    Ghosh M; Gauger M; Marcu A; Nelde A; Denk M; Schuster H; Rammensee HG; Stevanović S
    Mol Cell Proteomics; 2020 Mar; 19(3):432-443. PubMed ID: 31937595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosit-TMT: Deep Learning Boosts Identification of TMT-Labeled Peptides.
    Gabriel W; The M; Zolg DP; Bayer FP; Shouman O; Lautenbacher L; Schnatbaum K; Zerweck J; Knaute T; Delanghe B; Huhmer A; Wenschuh H; Reimer U; Médard G; Kuster B; Wilhelm M
    Anal Chem; 2022 May; 94(20):7181-7190. PubMed ID: 35549156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMBAS-MS Discovers Organ-Specific HLA Peptide Patterns in Plasma.
    Wahle M; Thielert M; Zwiebel M; Skowronek P; Zeng WF; Mann M
    Mol Cell Proteomics; 2024 Jan; 23(1):100689. PubMed ID: 38043703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors.
    Mei S; Ayala R; Ramarathinam SH; Illing PT; Faridi P; Song J; Purcell AW; Croft NP
    Mol Cell Proteomics; 2020 Jul; 19(7):1236-1247. PubMed ID: 32357974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Spectrometry Based Immunopeptidomics Leads to Robust Predictions of Phosphorylated HLA Class I Ligands.
    Solleder M; Guillaume P; Racle J; Michaux J; Pak HS; Müller M; Coukos G; Bassani-Sternberg M; Gfeller D
    Mol Cell Proteomics; 2020 Feb; 19(2):390-404. PubMed ID: 31848261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.
    Newey A; Griffiths B; Michaux J; Pak HS; Stevenson BJ; Woolston A; Semiannikova M; Spain G; Barber LJ; Matthews N; Rao S; Watkins D; Chau I; Coukos G; Racle J; Gfeller D; Starling N; Cunningham D; Bassani-Sternberg M; Gerlinger M
    J Immunother Cancer; 2019 Nov; 7(1):309. PubMed ID: 31735170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction.
    Pak H; Michaux J; Huber F; Chong C; Stevenson BJ; Müller M; Coukos G; Bassani-Sternberg M
    Mol Cell Proteomics; 2021; 20():100080. PubMed ID: 33845167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.
    Yaciuk JC; Skaley M; Bardet W; Schafer F; Mojsilovic D; Cate S; Stewart CJ; McMurtrey C; Jackson KW; Buchli R; Olvera A; Cedeño S; Plana M; Mothe B; Brander C; West JT; Hildebrand WH
    J Virol; 2014 Nov; 88(22):12992-3004. PubMed ID: 25165114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry.
    Phulphagar KM; Ctortecka C; Jacome ASV; Klaeger S; Verzani EK; Hernandez GM; Udeshi ND; Clauser KR; Abelin JG; Carr SA
    Mol Cell Proteomics; 2023 Jun; 22(6):100563. PubMed ID: 37142057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Spectrometry-Based Immunopeptidomics of Peptides Presented on Human Leukocyte Antigen Proteins.
    ElAbd H; Franke A
    Methods Mol Biol; 2024; 2758():425-443. PubMed ID: 38549028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.